Mortality and differential predictive factors of transient and persistent sepsis-associated acute kidney injury.

IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Clinical nephrology Pub Date : 2023-03-01 DOI:10.5414/CN110926
Weiheng Xia, Fang Yi, Qibing Wang
{"title":"Mortality and differential predictive factors of transient and persistent sepsis-associated acute kidney injury.","authors":"Weiheng Xia,&nbsp;Fang Yi,&nbsp;Qibing Wang","doi":"10.5414/CN110926","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The clinical outcomes and differential predictive factors for transient and persistent sepsis-associated AKI (SA-AKI) currently remain unclear. Therefore, using a large international database, this study aimed to compare the in-hospital mortality outcomes and determine the clinical factors for differentiating transient and persistent SA-AKI.</p><p><strong>Materials and methods: </strong>Patients with SA-AKI were identified from the Medical Information Mart for Intensive Care IV (MIMIC IV) database and divided into a persistent SA-AKI group and a transient SA-AKI group. In-hospital mortality rates between the two groups were compared. Logistic regression was performed to explore the risk factors, with the establishment of a clinical predictive model for transient or persistent SA-AKI.</p><p><strong>Results: </strong>Mortality rate of the persistent SA-AKI group was higher than of the transient SA-AKI group (p < 0.001). Persistent SA-AKI was an independent risk factor for in-hospital mortality. Factors including creatinine level at inclusion (OR 1.49, 95% CI 1.43 - 1.56, p < 0.001), changes of creatinine level (mg/dL) within 24 hours (OR 4.25, 95% CI 3.74 - 4.86, p < 0.001), continuous renal replacement therapy (CRRT) performed within 48 hours (OR 4.20, 95% CI 2.87 - 6.17), lactate level (mmol/L) (OR 1.18, 95% CI 1.05 - 1.12, p < 0.001) were independent risk factors for persistent SA-AKI. When incorporating these factors, the predictive model for persistent SA-AKI demonstrated good C-indexes of 0.80 (95% CI: 0.80 - 0.82) and 0.81 (95% CI: 0.79 - 0.83) in the training and validation cohorts, respectively, though the goodness-of-fit was poor.</p><p><strong>Conclusion: </strong>Persistent SA-AKI has a higher risk of in-hospital mortality than transient SA-AKI, whereby persistent SA-AKI is also an independent predictor of in-hospital mortality. The nomogram established by predictive factors can be applied in clinical practice to predict persistent SA-AKI.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/CN110926","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: The clinical outcomes and differential predictive factors for transient and persistent sepsis-associated AKI (SA-AKI) currently remain unclear. Therefore, using a large international database, this study aimed to compare the in-hospital mortality outcomes and determine the clinical factors for differentiating transient and persistent SA-AKI.

Materials and methods: Patients with SA-AKI were identified from the Medical Information Mart for Intensive Care IV (MIMIC IV) database and divided into a persistent SA-AKI group and a transient SA-AKI group. In-hospital mortality rates between the two groups were compared. Logistic regression was performed to explore the risk factors, with the establishment of a clinical predictive model for transient or persistent SA-AKI.

Results: Mortality rate of the persistent SA-AKI group was higher than of the transient SA-AKI group (p < 0.001). Persistent SA-AKI was an independent risk factor for in-hospital mortality. Factors including creatinine level at inclusion (OR 1.49, 95% CI 1.43 - 1.56, p < 0.001), changes of creatinine level (mg/dL) within 24 hours (OR 4.25, 95% CI 3.74 - 4.86, p < 0.001), continuous renal replacement therapy (CRRT) performed within 48 hours (OR 4.20, 95% CI 2.87 - 6.17), lactate level (mmol/L) (OR 1.18, 95% CI 1.05 - 1.12, p < 0.001) were independent risk factors for persistent SA-AKI. When incorporating these factors, the predictive model for persistent SA-AKI demonstrated good C-indexes of 0.80 (95% CI: 0.80 - 0.82) and 0.81 (95% CI: 0.79 - 0.83) in the training and validation cohorts, respectively, though the goodness-of-fit was poor.

Conclusion: Persistent SA-AKI has a higher risk of in-hospital mortality than transient SA-AKI, whereby persistent SA-AKI is also an independent predictor of in-hospital mortality. The nomogram established by predictive factors can be applied in clinical practice to predict persistent SA-AKI.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
短暂性和持续性败血症相关急性肾损伤的死亡率和差异预测因素。
背景:暂时性和持续性败血症相关性AKI (SA-AKI)的临床结局和差异预测因素目前尚不清楚。因此,本研究利用大型国际数据库,旨在比较住院死亡率结果,并确定区分短暂性和持续性SA-AKI的临床因素。材料和方法:从重症监护医学信息市场IV (MIMIC IV)数据库中确定SA-AKI患者,并将其分为持续性SA-AKI组和短暂性SA-AKI组。比较两组患者的住院死亡率。通过Logistic回归分析危险因素,建立短暂性或持续性SA-AKI的临床预测模型。结果:持续性SA-AKI组死亡率高于短暂性SA-AKI组(p < 0.001)。持续性SA-AKI是院内死亡的独立危险因素。纳入时肌酐水平(OR 1.49, 95% CI 1.43 - 1.56, p < 0.001)、24小时内肌酐水平(mg/dL)的变化(OR 4.25, 95% CI 3.74 - 4.86, p < 0.001)、48小时内进行的持续肾替代治疗(OR 4.20, 95% CI 2.87 - 6.17)、乳酸水平(OR 1.18, 95% CI 1.05 - 1.12, p < 0.001)是持续性SA-AKI的独立危险因素。当纳入这些因素时,持续性SA-AKI的预测模型在训练组和验证组中分别显示出良好的c指数为0.80 (95% CI: 0.80 - 0.82)和0.81 (95% CI: 0.79 - 0.83),尽管拟合优度较差。结论:持续性SA-AKI的院内死亡率高于短暂性SA-AKI,因此持续性SA-AKI也是院内死亡率的独立预测因子。由预测因素建立的nomogram可用于临床预测持续性SA-AKI。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical nephrology
Clinical nephrology 医学-泌尿学与肾脏学
CiteScore
2.10
自引率
9.10%
发文量
138
审稿时长
4-8 weeks
期刊介绍: Clinical Nephrology appears monthly and publishes manuscripts containing original material with emphasis on the following topics: prophylaxis, pathophysiology, immunology, diagnosis, therapy, experimental approaches and dialysis and transplantation.
期刊最新文献
Microarray analysis of microRNA profiles for assessing the therapeutic effects of sodium thiosulfate on end-stage renal disease combined with coronary artery calcification. Drug-induced acute tubulointerstitial nephritis: Serial C-reactive protein measurements might predict the course of acute kidney injury. Association of vitamin intake with health-related quality of life in hemodialysis patients. Denosumab for immobilization-induced hypercalcemia in patients with end-stage renal disease. Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1